Unknown OBSERVATIONAL NCT01748435

Pre-emptive Analgesia With Qutenza in Lower Limb Amputation

The Role of Pre-emptive Analgesia With Qutenza (Topical Capsaicin 8%) in Preventing Neuropathic Pain Following Lower Limb Amputation: a Pilot Randomised Controlled Study

Sponsor: NHS Greater Glasgow and Clyde

Conditions Lower Limb Amputation Neuropathic Pain

Interventions Qutenza

Updated 5 times since 2017 Last updated: Dec 10, 2012 Started: Feb 28, 2013 Primary completion: Feb 28, 2014 Completion: May 31, 2014

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01748435, this observational or N/A phase trial focuses on Lower Limb Amputation and Neuropathic Pain and remains ongoing. Sponsored by NHS Greater Glasgow and Clyde, it has been updated 5 times since 2013, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Unknown
Jul 2024 — Sep 2024 [monthly]

Unknown

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status
Apr 2018 — Jan 2021 [monthly]

Unknown Status

Phase: NA → None
Jan 2017 — Apr 2018 [monthly]

Unknown Status NA

First recorded

Feb 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

NHS Greater Glasgow and Clyde

Data source: NHS Greater Glasgow and Clyde

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Glasgow, United Kingdom